Table 2 Body weight average at evaluated periods.

From: Morphological and biomechanical characterization of long bones and peri-implant bone repair in type 2 diabetic rats treated with resveratrol

Group

Day 0

Day 21

Day 28

Day 43

Day 73

NG

374.5 mg ± 22.53a

401.5 mg ± 22.86a.b

415.5 mg ± 21.1b.c

432.3 mg ± 21.56c

478.9 mg ± 23.73d

NGrvt

341.7 mg ± 24.64a

360.5 mg ± 21a.b

366.7 mg ± 22.18a.d

376.5 mg ± 26.86b.c.d

401.2 mg ± 23.68c

T2D

427.7 mg ± 12.33a.c

501 mg ± 32.15b

476.3 mg ± 40.16b.c

447.3 mg ± 42.21a.b

419.5 mg ± 72.61a

T2Drvt

435.5 mg ± 36.91a

493.1 mg ± 55.84a

483.1 mg ± 57.21a

481.4 mg ± 63.87a

517 mg ± 80.43a

  1. Day 0 = Beginning of the diet; Day 21 = STZ application; Day 28 = Diabetes confirmation/start of resveratrol treatment; Day 43 = implant surgery; and Day 73 = euthanasia. The letters indicate a statistical difference between the periods.